Abstract

The bioavailability of RRR-α-tocopherol from the oral administration of RRR-α-tocopherol itself and its acetate and succinate esters was determined in healthy human subjects. Venous blood samples were withdrawn periodically over a 51-h period following oral administration of a gelatin capsule containing an equimolar mixture of RRR-α-tocopherol and RRR-α-tocopheryl acetate. In a second study, subjects received a capsule containing an equimolar mixture of RRR-α-tocopheryl acetate and RRR-α-tocopheryl succinate. In Study 1, RRR-α-tocopherol was absorbed at similar rates from both the free phenol, and the acetate ester and maximum plasma levels occurred at 12 h in most subjects. The extent of absorption of RRR-α-tocopherol varied considerably between subjects in absolute terms, but the relative absorption from the two forms was remarkably consistent, and a ratio of 1.0 was found for parameters of relative bioavailability in plasma. The concentration of RRR-α-tocopherol from each form was maximal at approximately 27 h in red blood cells and, as seen with the plasma data, there was a large inter-individual variability. In Study 2, there was no significant difference in the extent of absorption of RRR-α-tocopherol from the acetate ester and the succinate ester, although there was an apparently higher initial rate of absorption from the acetate ester.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.